Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 126,300 | 88,100 | 25,800 | -900 | -11,400 |
| Depreciation Amortization | 97,300 | 64,800 | 33,200 | 159,300 | 121,900 |
| Income taxes - deferred | 25,100 | 21,900 | 13,300 | -41,600 | -29,600 |
| Accounts receivable | -65,200 | -93,400 | -51,000 | 100,300 | 45,900 |
| Accounts payable and accrued liabilities | 71,500 | 104,900 | 76,100 | 17,600 | 39,100 |
| Other Working Capital | -74,400 | -60,500 | -37,500 | 392,400 | 320,700 |
| Other Operating Activity | 1,800 | -1,400 | -21,800 | -61,800 | -90,400 |
| Operating Cash Flow | $182,400 | $124,400 | $38,100 | $565,300 | $396,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -76,600 | -52,900 | -27,900 | -175,500 | -159,400 |
| Other Investing Activity | -7,200 | -1,000 | 600 | -11,400 | 7,000 |
| Investing Cash Flow | $-83,800 | $-53,900 | $-27,300 | $-186,900 | $-152,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,400 | -1,500 | 1,200 | -29,900 | -25,400 |
| Debt Issued | N/A | N/A | N/A | 390,200 | 390,200 |
| Debt Repayment | -18,400 | -15,500 | -15,200 | -532,800 | -517,500 |
| Common Stock Issued | 17,700 | 8,600 | 6,700 | 7,400 | 1,600 |
| Dividend Paid | -3,200 | -2,500 | -1,900 | -9,200 | -8,600 |
| Other Financing Activity | 2,900 | 800 | 800 | 0 | 0 |
| Financing Cash Flow | $-3,400 | $-10,100 | $-8,400 | $-174,300 | $-159,700 |
| Exchange Rate Effect | 200 | -10,600 | -2,200 | 2,300 | 4,000 |
| Beginning Cash Position | 261,700 | 261,700 | 261,700 | 55,300 | 55,300 |
| End Cash Position | 357,100 | 311,500 | 261,900 | 261,700 | 143,400 |
| Net Cash Flow | $95,400 | $49,800 | $200 | $206,400 | $88,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 182,400 | 124,400 | 38,100 | 565,300 | 396,200 |
| Capital Expenditure | -76,600 | -52,900 | -27,900 | -175,500 | -159,400 |
| Free Cash Flow | 105,800 | 71,500 | 10,200 | 389,800 | 236,800 |